Deep learning-based radiomics: pacing immunotherapy in lung cancer
- PMID: 37268450
- DOI: 10.1016/S2589-7500(23)00086-9
Deep learning-based radiomics: pacing immunotherapy in lung cancer
Conflict of interest statement
We declare no competing interests.
Comment on
-
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.Lancet Digit Health. 2023 Jul;5(7):e404-e420. doi: 10.1016/S2589-7500(23)00082-1. Epub 2023 May 31. Lancet Digit Health. 2023. PMID: 37268451 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical